We believe GLP-1 therapy is a serious medical intervention that requires baseline assessment, ongoing monitoring, and personalized optimization
Stimuli-responsive release strategies that respond to glucose levels, pH shifts, and redox conditions restrict drug activation to diseased microenvironments
T.JonesK
3,28 One approach is to prevent degradation by DPP-IV through amino acid substitutions, as this enzyme preferentially cleaves N-terminal Xaa-Pro or Xaa-Ala sequences
Always carry a signed clinician's letter confirming diagnosis, medication name, dosage, and medical necessity, plus original labelled packaging and a copy of your prescription
Bacterial LPS is a common mechanism to stimulate microglia activation of pro-inflammatory cytokine release